1
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiogenesis Technologies, Seed and Berry, February 10, 1998: US05716981 (778 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


2
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiotech Pharmaceuticals, Seed and Berry, March 23, 1999: US05886026 (293 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


3
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiotech Pharmaceuticals, Seed Intellectual Property Law Group PLLC, April 8, 2003: US06544544 (182 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


4
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiotech Pharmaceuticals, SEED Intellectual Property Law Group PLLC, January 14, 2003: US06506411 (95 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also, provided are methods for embolizing blood vessels, ...


5
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic Compositions and methods for the treatment of arthritis. Angiogenesis Technologies, Seed & Berry, November 30, 1999: US05994341 (74 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


6
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiotech Pharmaceuticals, Seed IP Law Group PLLC, January 25, 2005: US06846841 (63 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


7
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Seed Intellectual Property Law Group Pllc, January 2, 2003: US20030003094-A1 (2 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


8
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiotech Pharmaceuticals, Seed Intellectual Property Law Group Pllc, January 2, 2003: US20030004209-A1 (2 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


9
William L Hunter, Lindsay S Machan, A Larry Arsenault, Helen M Burt, John K Jackson, Stephen K Dordunoo: Anti-angiogenic compositions and methods of use. Seed Intellectual Property Law Group Pllc, August 29, 2002: US20020119202-A1 (2 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


10
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiotech Pharmaceuticals, Oblon Spivak McClelland Maier & Neustadt L, October 26, 2010: US07820193 (1 worldwide citation)

The present invention is directed to a stent comprising (a) a balloon expandable coronary stent; and (b) paclitaxel, in an amount that when tested in a chick chorioallantoic membrane assay is anti-angiogenic.